<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<ruleSet xmlns="http://semanticbits.com/rules/brxml"><id>83076f8c-2baa-4af6-8222-f9338de4e3b0</id><name>gov.nih.nci.cabig.caaers.rules.sponsor.study.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.cancer_therapy_evaluation_program.sae_reporting_rules</name><description>SAE Reporting Rules</description><subject>Sponsor defined rules for a study||Cancer Therapy Evaluation Program||A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</subject><coverage>Enabled</coverage><import>gov.nih.nci.cabig.caaers.domain.*</import><rule id="b993549b-e6b2-4e5b-8120-e5a8328b7a1b"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study " grammer-postfix="" field-name="phaseCode" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Phase I Trial</value><value>Phase I/II Trial</value><readable-value>Phase I/II Trial,Phase I Trial,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,null,'phaseCode','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Agent IND Holder " grammer-postfix="" field-name="investigationalNewDrugIndicator" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Cancer Therapy Evaluation Program</value><readable-value>Cancer Therapy Evaluation Program</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.InvestigationalNewDrug','holderName','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>3</value><readable-value>Grade 3</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Hospitalization or Prolonged Hospitalization " grammer-postfix="" field-name="hospitalization" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>1</value><readable-value>none,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Hospitalization','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>false</value><readable-value>is not </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP 24 Hour SAE Notification</action><action>CTEP 5 Calendar Day SAE Report</action><readableAction>CTEP 24 Hour SAE Notification</readableAction><readableAction>CTEP 5 Calendar Day SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-1" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study is  'Phase I/II Trial'  or 'Phase I Trial' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Agent IND Holder is  'Cancer Therapy Evaluation Program' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is  'Grade 3' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Hospitalization or Prolonged Hospitalization is not  'none' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is not ' expected </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is not  'Unlikely'  or 'Unrelated' </line></readableRule></rule><rule id="9b0b04cc-944e-4601-90e0-63338f4a8112"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study " grammer-postfix="" field-name="phaseCode" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Phase I Trial</value><value>Phase I/II Trial</value><readable-value>Phase I/II Trial,Phase I Trial,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,null,'phaseCode','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Agent IND Holder " grammer-postfix="" field-name="investigationalNewDrugIndicator" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Cancer Therapy Evaluation Program</value><readable-value>Cancer Therapy Evaluation Program</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.InvestigationalNewDrug','holderName','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>3</value><readable-value>Grade 3</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Hospitalization or Prolonged Hospitalization " grammer-postfix="" field-name="hospitalization" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>1</value><readable-value>Yes</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Hospitalization','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>false</value><readable-value>is not </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP 10 Calendar Day SAE Report</action><readableAction>CTEP 10 Calendar Day SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-2" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study is  'Phase I/II Trial'  or 'Phase I Trial' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Agent IND Holder is  'Cancer Therapy Evaluation Program' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is  'Grade 3' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Hospitalization or Prolonged Hospitalization is  'Yes' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is not ' expected </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is  'Unlikely'  or 'Unrelated' </line></readableRule></rule><rule id="327f353e-13b9-4fd1-a937-5a2b450fd6e5"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study " grammer-postfix="" field-name="phaseCode" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Phase I Trial</value><value>Phase I/II Trial</value><readable-value>Phase I/II Trial,Phase I Trial,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,null,'phaseCode','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Agent IND Holder " grammer-postfix="" field-name="investigationalNewDrugIndicator" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Cancer Therapy Evaluation Program</value><readable-value>Cancer Therapy Evaluation Program</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.InvestigationalNewDrug','holderName','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>3</value><readable-value>Grade 3</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Hospitalization or Prolonged Hospitalization " grammer-postfix="" field-name="hospitalization" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>1</value><readable-value>Yes</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Hospitalization','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>false</value><readable-value>is not </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP 24 Hour SAE Notification</action><action>CTEP 5 Calendar Day SAE Report</action><readableAction>CTEP 24 Hour SAE Notification</readableAction><readableAction>CTEP 5 Calendar Day SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-3" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study is  'Phase I/II Trial'  or 'Phase I Trial' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Agent IND Holder is  'Cancer Therapy Evaluation Program' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is  'Grade 3' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Hospitalization or Prolonged Hospitalization is  'Yes' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is not ' expected </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is not  'Unlikely'  or 'Unrelated' </line></readableRule></rule><rule id="4984b60c-8d53-4172-a88e-a34ae601b279"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study " grammer-postfix="" field-name="phaseCode" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Phase I Trial</value><value>Phase I/II Trial</value><readable-value>Phase I/II Trial,Phase I Trial,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,null,'phaseCode','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Agent IND Holder " grammer-postfix="" field-name="investigationalNewDrugIndicator" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Cancer Therapy Evaluation Program</value><readable-value>Cancer Therapy Evaluation Program</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.InvestigationalNewDrug','holderName','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>3</value><readable-value>Grade 3</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Hospitalization or Prolonged Hospitalization " grammer-postfix="" field-name="hospitalization" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>1</value><readable-value>Yes</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Hospitalization','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>true</value><readable-value>is </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP 10 Calendar Day SAE Report</action><readableAction>CTEP 10 Calendar Day SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-4" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study is  'Phase I/II Trial'  or 'Phase I Trial' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Agent IND Holder is  'Cancer Therapy Evaluation Program' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is  'Grade 3' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Hospitalization or Prolonged Hospitalization is  'Yes' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is ' expected </line></readableRule></rule><rule id="0901a73e-ff3f-4dba-ae66-baf50a3fa1e3"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study " grammer-postfix="" field-name="phaseCode" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Phase I Trial</value><value>Phase I/II Trial</value><readable-value>Phase I/II Trial,Phase I Trial,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,null,'phaseCode','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Agent IND Holder " grammer-postfix="" field-name="investigationalNewDrugIndicator" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Cancer Therapy Evaluation Program</value><readable-value>Cancer Therapy Evaluation Program</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.InvestigationalNewDrug','holderName','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="&gt;=" display-uri="is greater than or equal to "><value>4</value><readable-value>Grade 4</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP 24 Hour SAE Notification</action><action>CTEP 5 Calendar Day SAE Report</action><readableAction>CTEP 24 Hour SAE Notification</readableAction><readableAction>CTEP 5 Calendar Day SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-5" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study is  'Phase I/II Trial'  or 'Phase I Trial' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Agent IND Holder is  'Cancer Therapy Evaluation Program' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is greater than or equal to  'Grade 4' </line></readableRule></rule><rule id="1a8084e8-a30a-4700-b4b5-d0ec0d59c14a"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study " grammer-postfix="" field-name="phaseCode" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Phase I Trial</value><value>Phase I/II Trial</value><readable-value>Phase I/II Trial,Phase I Trial,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,null,'phaseCode','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Agent IND Holder " grammer-postfix="" field-name="investigationalNewDrugIndicator" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Cancer Therapy Evaluation Program</value><readable-value>Cancer Therapy Evaluation Program</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.InvestigationalNewDrug','holderName','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>2</value><readable-value>Grade 2</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>false</value><readable-value>is not </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP 10 Calendar Day SAE Report</action><readableAction>CTEP 10 Calendar Day SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-6" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study is  'Phase I/II Trial'  or 'Phase I Trial' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Agent IND Holder is  'Cancer Therapy Evaluation Program' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is  'Grade 2' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is not ' expected </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is not  'Unlikely'  or 'Unrelated' </line></readableRule></rule><rule id="0daf2ecf-1d06-4a7e-8602-f01480e46c08"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study " grammer-postfix="" field-name="phaseCode" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Phase II Trial</value><value>Phase III Trial</value><readable-value>Phase III Trial,Phase II Trial,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,null,'phaseCode','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Agent IND Holder " grammer-postfix="" field-name="investigationalNewDrugIndicator" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Cancer Therapy Evaluation Program</value><readable-value>Cancer Therapy Evaluation Program</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.InvestigationalNewDrug','holderName','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>2</value><readable-value>Grade 2</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>false</value><readable-value>is not </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP 10 Calendar Day SAE Report</action><readableAction>CTEP 10 Calendar Day SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-7" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study is  'Phase III Trial'  or 'Phase II Trial' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Agent IND Holder is  'Cancer Therapy Evaluation Program' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is  'Grade 2' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is not ' expected </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is not  'Unlikely'  or 'Unrelated' </line></readableRule></rule><rule id="ac876458-579c-4f1b-a818-d2a02083bde9"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study " grammer-postfix="" field-name="phaseCode" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Phase II Trial</value><value>Phase III Trial</value><readable-value>Phase III Trial,Phase II Trial,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,null,'phaseCode','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Agent IND Holder " grammer-postfix="" field-name="investigationalNewDrugIndicator" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Cancer Therapy Evaluation Program</value><readable-value>Cancer Therapy Evaluation Program</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.InvestigationalNewDrug','holderName','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>3</value><readable-value>Grade 3</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>false</value><readable-value>is not </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Hospitalization or Prolonged Hospitalization " grammer-postfix="" field-name="hospitalization" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>1</value><readable-value>Yes</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Hospitalization','code','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP 10 Calendar Day SAE Report</action><readableAction>CTEP 10 Calendar Day SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-8" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study is  'Phase III Trial'  or 'Phase II Trial' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Agent IND Holder is  'Cancer Therapy Evaluation Program' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is  'Grade 3' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is not ' expected </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Hospitalization or Prolonged Hospitalization is  'Yes' </line></readableRule></rule><rule id="e7e8e035-15ad-497b-9517-5ab8b6afbf4c"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study " grammer-postfix="" field-name="phaseCode" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Phase II Trial</value><value>Phase III Trial</value><readable-value>Phase III Trial,Phase II Trial,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,null,'phaseCode','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Agent IND Holder " grammer-postfix="" field-name="investigationalNewDrugIndicator" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Cancer Therapy Evaluation Program</value><readable-value>Cancer Therapy Evaluation Program</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.InvestigationalNewDrug','holderName','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>3</value><readable-value>Grade 3</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Hospitalization or Prolonged Hospitalization " grammer-postfix="" field-name="hospitalization" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>1</value><readable-value>none,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Hospitalization','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>false</value><readable-value>is not </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP 10 Calendar Day SAE Report</action><readableAction>CTEP 10 Calendar Day SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-9" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study is  'Phase III Trial'  or 'Phase II Trial' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Agent IND Holder is  'Cancer Therapy Evaluation Program' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is  'Grade 3' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Hospitalization or Prolonged Hospitalization is not  'none' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is not ' expected </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is not  'Unlikely'  or 'Unrelated' </line></readableRule></rule><rule id="9d11ef17-ecf3-4aaf-8204-9d19ff209752"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study " grammer-postfix="" field-name="phaseCode" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Phase II Trial</value><value>Phase III Trial</value><readable-value>Phase III Trial,Phase II Trial,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,null,'phaseCode','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Agent IND Holder " grammer-postfix="" field-name="investigationalNewDrugIndicator" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Cancer Therapy Evaluation Program</value><readable-value>Cancer Therapy Evaluation Program</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.InvestigationalNewDrug','holderName','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>3</value><readable-value>Grade 3</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Hospitalization or Prolonged Hospitalization " grammer-postfix="" field-name="hospitalization" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>1</value><readable-value>Yes</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Hospitalization','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>true</value><readable-value>is </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP 10 Calendar Day SAE Report</action><readableAction>CTEP 10 Calendar Day SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-10" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study is  'Phase III Trial'  or 'Phase II Trial' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Agent IND Holder is  'Cancer Therapy Evaluation Program' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is  'Grade 3' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Hospitalization or Prolonged Hospitalization is  'Yes' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is ' expected </line></readableRule></rule><rule id="253828ff-71e7-4f7c-bb2d-8e142149221d"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study " grammer-postfix="" field-name="phaseCode" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Phase II Trial</value><value>Phase III Trial</value><readable-value>Phase III Trial,Phase II Trial,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,null,'phaseCode','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Agent IND Holder " grammer-postfix="" field-name="investigationalNewDrugIndicator" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Cancer Therapy Evaluation Program</value><readable-value>Cancer Therapy Evaluation Program</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.InvestigationalNewDrug','holderName','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="&gt;=" display-uri="is greater than or equal to "><value>4</value><readable-value>Grade 4</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>true</value><readable-value>is </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP 10 Calendar Day SAE Report</action><readableAction>CTEP 10 Calendar Day SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-11" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study is  'Phase III Trial'  or 'Phase II Trial' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Agent IND Holder is  'Cancer Therapy Evaluation Program' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is greater than or equal to  'Grade 4' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is ' expected </line></readableRule></rule><rule id="b61adec6-fa5b-4583-97cb-768a91917a4a"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study " grammer-postfix="" field-name="phaseCode" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Phase II Trial</value><value>Phase III Trial</value><readable-value>Phase III Trial,Phase II Trial,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,null,'phaseCode','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Agent IND Holder " grammer-postfix="" field-name="investigationalNewDrugIndicator" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Cancer Therapy Evaluation Program</value><readable-value>Cancer Therapy Evaluation Program</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.InvestigationalNewDrug','holderName','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="&gt;=" display-uri="is greater than or equal to "><value>4</value><readable-value>Grade 4</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>false</value><readable-value>is not </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP 10 Calendar Day SAE Report</action><readableAction>CTEP 10 Calendar Day SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-12" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study is  'Phase III Trial'  or 'Phase II Trial' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Agent IND Holder is  'Cancer Therapy Evaluation Program' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is greater than or equal to  'Grade 4' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is not ' expected </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is  'Unlikely'  or 'Unrelated' </line></readableRule></rule><rule id="d7b8aca1-714e-4bfb-9efd-4dc877c5df75"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study " grammer-postfix="" field-name="phaseCode" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Phase II Trial</value><value>Phase III Trial</value><readable-value>Phase III Trial,Phase II Trial,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,null,'phaseCode','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Agent IND Holder " grammer-postfix="" field-name="investigationalNewDrugIndicator" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Cancer Therapy Evaluation Program</value><readable-value>Cancer Therapy Evaluation Program</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.InvestigationalNewDrug','holderName','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="&gt;=" display-uri="is greater than or equal to "><value>4</value><readable-value>Grade 4</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>false</value><readable-value>is not </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP 24 Hour SAE Notification</action><action>CTEP 5 Calendar Day SAE Report</action><readableAction>CTEP 24 Hour SAE Notification</readableAction><readableAction>CTEP 5 Calendar Day SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-13" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study is  'Phase III Trial'  or 'Phase II Trial' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Agent IND Holder is  'Cancer Therapy Evaluation Program' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is greater than or equal to  'Grade 4' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is not ' expected </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is not  'Unlikely'  or 'Unrelated' </line></readableRule></rule><rule id="10760e21-bd4f-4a7b-99e6-2934fb635e7a"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Agent IND Holder " grammer-postfix="" field-name="investigationalNewDrugIndicator" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>Cancer Therapy Evaluation Program</value><readable-value>Cancer Therapy Evaluation Program</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.InvestigationalNewDrug','holderName','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="&gt;=" display-uri="is greater than or equal to "><value>4</value><readable-value>Grade 4</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>false</value><readable-value>is not </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP 10 Calendar Day SAE Report</action><readableAction>CTEP 10 Calendar Day SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-14" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Agent IND Holder is not  'Cancer Therapy Evaluation Program' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is greater than or equal to  'Grade 4' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is not ' expected </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is not  'Unlikely'  or 'Unrelated' </line></readableRule></rule><rule id="eb195e98-c784-4df1-8eac-11fd45a039fb"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Investigational new drug? " grammer-postfix="(Commercially Available Agent Only)" field-name="StudyAgentIndIndicator" display-uri="undefined"><literal-restriction evaluator="isOnly" display-uri="is "><value>false</value><readable-value>No </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.StudyAgent','investigationalNewDrugIndicator','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="&gt;=" display-uri="is greater than or equal to "><value>4</value><readable-value>Grade 4</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>false</value><readable-value>is not </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP Commercial Intervention SAE Report</action><readableAction>CTEP Commercial Intervention SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-15" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Investigational new drug? is  'No ' (Commercially Available Agent Only)</line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is greater than or equal to  'Grade 4' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is not  'Unlikely'  or 'Unrelated' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is not ' expected </line></readableRule></rule><rule id="7e81fb56-bdef-48b7-bf9b-dc98fccc9dad"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Agent IND Holder " grammer-postfix="" field-name="investigationalNewDrugIndicator" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Cancer Therapy Evaluation Program</value><readable-value>Cancer Therapy Evaluation Program</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.InvestigationalNewDrug','holderName','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study " grammer-postfix="" field-name="phaseCode" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Phase II Trial</value><value>Phase III Trial</value><readable-value>Phase III Trial,Phase II Trial,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,null,'phaseCode','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>2</value><readable-value>Grade 2</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>false</value><readable-value>is not </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>CTEP 10 Calendar Day SAE Report</action><readableAction>CTEP 10 Calendar Day SAE Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-16" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Agent IND Holder is  'Cancer Therapy Evaluation Program' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study is  'Phase III Trial'  or 'Phase II Trial' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is  'Grade 2' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is not ' expected </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is not  'Unlikely'  or 'Unrelated' </line></readableRule></rule><rule id="ff201705-4813-458d-bba8-2e67c483298b"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Category " grammer-postfix="" field-name="category" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>303</value><readable-value>BLOOD/BONE MARROW</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.CtcCategory','id','0','&gt;')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Term " grammer-postfix="" field-name="term" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>3020</value><value>3021</value><value>3023</value><value>3024</value><readable-value>Leukocytes (total WBC),Lymphopenia,Neutrophils/granulocytes (ANC/AGC),Platelets</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.CtcTerm','id','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="&lt;=" display-uri="is less than or equal to "><value>3</value><readable-value>Grade 3</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>IGNORE</action><readableAction>IGNORE</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-17" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Category is  'BLOOD/BONE MARROW' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Term is  'Leukocytes (total WBC)'  or 'Lymphopenia'  or 'Neutrophils/granulocytes (ANC/AGC)'  or 'Platelets' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is less than or equal to  'Grade 3' </line></readableRule></rule><rule id="d95bea53-86e5-4112-a934-02efc546b2d5"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Category " grammer-postfix="" field-name="category" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>303</value><readable-value>BLOOD/BONE MARROW</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.CtcCategory','id','0','&gt;')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Term " grammer-postfix="" field-name="term" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>3017</value><readable-value>Hemoglobin</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.CtcTerm','id','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="&lt;=" display-uri="is less than or equal to "><value>3</value><readable-value>Grade 3</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>true</value><readable-value>is </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","==")</expression></column></condition><action>IGNORE</action><readableAction>IGNORE</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rule.sponsor.study.cancer_therapy_evaluation_program.a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma.sae_reporting_rules" name="Rule-18" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/a_phase_ii_trial_of_17_n_allylamino_17_demethoxygeldanamycin__17_aag__in_combination_with_gemcitabine_in_patients_with_metastatic_pancreatic_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Category is  'BLOOD/BONE MARROW' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Term is  'Hemoglobin' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is less than or equal to  'Grade 3' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is ' expected </line></readableRule></rule></ruleSet>

